Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Nov;62(5):865–867. doi: 10.1038/bjc.1990.396

Oncofetal markers CA 19-9, CA 125 and SP1 in healthy children and in children with malignancy.

M Heikinheimo 1, J Rajantie 1, P Kuusela 1, M J Kallio 1, M A Siimes 1
PMCID: PMC1971508  PMID: 2245182

Full text

PDF
865

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bast R. C., Jr, Klug T. L., St John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med. 1983 Oct 13;309(15):883–887. doi: 10.1056/NEJM198310133091503. [DOI] [PubMed] [Google Scholar]
  2. Haglund C., Lindgren J., Roberts P. J., Nordling S. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis. Br J Cancer. 1986 Feb;53(2):189–195. doi: 10.1038/bjc.1986.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Haglund C., Roberts P. J., Kuusela P., Scheinin T. M., Mäkelä O., Jalanko H. Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer. 1986 Feb;53(2):197–202. doi: 10.1038/bjc.1986.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Halila H., Stenman U. H., Seppälä M. Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy. Cancer. 1986 Apr 1;57(7):1327–1329. doi: 10.1002/1097-0142(19860401)57:7<1327::aid-cncr2820570713>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  5. Heikinheimo M., Gahmberg C. G., Bohn H., Andersson L. C. Oncoplacental protein SP1--a constitutive and inducible late differentiation marker of the human myelomonocytic lineage. Blood. 1987 Nov;70(5):1279–1283. [PubMed] [Google Scholar]
  6. Herlyn M., Sears H. F., Steplewski Z., Koprowski H. Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J Clin Immunol. 1982 Apr;2(2):135–140. doi: 10.1007/BF00916897. [DOI] [PubMed] [Google Scholar]
  7. Kallio M. J., Siimes M. A., Perheentupa J., Salmenperä L., Miettinen T. A. Cholesterol and its precursors in human milk during prolonged exclusive breast-feeding. Am J Clin Nutr. 1989 Oct;50(4):782–785. doi: 10.1093/ajcn/50.4.782. [DOI] [PubMed] [Google Scholar]
  8. Koprowski H., Steplewski Z., Mitchell K., Herlyn M., Herlyn D., Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet. 1979 Nov;5(6):957–971. doi: 10.1007/BF01542654. [DOI] [PubMed] [Google Scholar]
  9. Rooney B. C., Horne C. H., Hardman N. Molecular cloning of a cDNA for human pregnancy-specific beta 1-glycoprotein:homology with human carcinoembryonic antigen and related proteins. Gene. 1988 Nov 30;71(2):439–449. doi: 10.1016/0378-1119(88)90061-3. [DOI] [PubMed] [Google Scholar]
  10. Rosen S. W., Kaminska J., Calvert I. S., Aaronson S. A. Human fibroblasts produce "pregnancy-specific" beta-1 glycoprotein in vitro. Am J Obstet Gynecol. 1979 Aug 1;134(7):734–738. doi: 10.1016/0002-9378(79)90938-4. [DOI] [PubMed] [Google Scholar]
  11. Ruoslahti E., Seppälä M. Studies of carcino-fetal proteins. 3. Development of a radioimmunoassay for -fetoprotein. Demonstration of -fetoprotein in serum of healthy human adults. Int J Cancer. 1971 Nov 15;8(3):374–383. doi: 10.1002/ijc.2910080304. [DOI] [PubMed] [Google Scholar]
  12. Rutanen E. M., Seppälä M. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease. J Clin Endocrinol Metab. 1980 Jan;50(1):57–61. doi: 10.1210/jcem-50-1-57. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES